Funding for this research was provided by:
National Science Foundation (ACI-16449916)
National Institutes of Health (R01MH121433, R01MH118349, R01MH120125, R01NS110791)
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (P30 CA016086, P30 NS045892)
North Carolina Biotech Center (2016-IDG-1016)
Received: 22 January 2021
Accepted: 17 May 2021
First Online: 22 May 2021
: The user survey was deemed exempt by the UNC Office of Human Research Ethics (IRB 20–3341). Interested study participants were provided a standard IRB-approved consent form and completed a Qualtrics survey determined to meet University data security requirements (see Additional File InternalRef removed). Consent from study participants was indicated by return of the completed survey.
: Not applicable.
: The authors declare that they have no competing interests.